Understanding the Human Gut Microbiota impacts in Neurodegenerative Disorders: A Correlative Approach

A person’s physiology is mostly influenced by the microbiota present in their gut. Studies revealed myriad patterns of microbiome composition at various stages of life, with major alterations in the dominating phyla and species identified as age progresses. Notably, the quantity of Actinobacteria declines after weaning, whereas Firmicutes and Bacteroidetes increase in prevalence, particularly in older individuals. When the gut microbiota is compromised, the entire body is impacted. Diverse human illnesses are related to the onset and progression of gut microbiota dysbiosis. During the last ten years, research has been aimed at the interactions that occur between the gut microbiota and other body systems, such as the immunological, neurological, and metabolic systems. Neurodegenerative diseases (NDs) are defined as the gradual decline in selectively susceptible neurons. Worldwide, people face significant medical and public health challenges as a result of degenerative illnesses of the neurological system. Among the most common neurological disorders are Parkinson’s disease (PD), Alzheimer’s disease (AD), and amyotrophic lateral sclerosis (ALS). These illnesses have a sharp increase in incidence and frequency as people age. There has been increasing curiosity regarding the connection between brain development and gut bacteria. Germ-free (GF) mice were shown to exhibit higher levels of motor activity and a decrease in anxiety-like responses in comparison to specific-pathogen-free (SPF) mice. The blood–brain barrier (BBB) is crucial in regulating the flow of nutrients, as well as chemicals, between the blood and the brain. The GF mice exhibited higher blood–brain barrier permeability in comparison to SPF mice. The Pavlov pouch, an externalized section of the dog intestine used to research canine digestive processes, was contributed by Ivan Pavlov, who, as well as defining classical conditioning, was also a forerunner in the arena of the gut–brain axis (GBA). He refined the methods by preserving innervation to the intestine section, enabling more precise monitoring of digestive processes in real time over prolonged periods. The GBA, is a two-way interaction that mediates the significant influence of bacteria on physiological processes in the brain. Neurotransmitters and other metabolites are used by the gut–brain axis to engage in bidirectional communication between the brain and the gut. Many clinical and experimental studies have revealed the significance of the microbiota in NDs via different microbial chemicals that travel through the GBA or neurological system from the gut to the brain. The central, autonomous, and enteric neural systems, together with the immunological, endocrine, and metabolic systems, are all involved in the communication process. However, the precise mechanism regulating the signal propagation and stimulating alterations in host diseases is still unknown. Through these pathways, the metabolites of the gut microbiota, which include SCFAs, histamine, gamma-aminobutyric acid (GABA), norepinephrine, serotonin, etc., affect several cerebral physiological functions. An imbalance in the composition of the gut microbiome, causes the brain to receive signals that lead to low-grade inflammation, increased oxidative stress, disturbed energy metabolism, and increased cellular aging. These pathological processes are involved in a variety of neurological diseases.